report cover1

Cushing Syndrome Market - Global Industry, Analysis, Size, Share, Growth, Trends, and Forecasts 2023-2030

Cushing’s syndrome is a collection of signs and symptoms due to prolonged exposure to glucocorticoids such as cortisol. Signs and symptoms may include high blood pressure, abdominal obesity but with thin arms and legs, reddish stretch marks, a round red face due to facial plethora, a fat lump between the shoulders, weak muscles, weak bones, acne, and fragile skin that heals poorly. Women may have more hair and irregular menstruation. Occasionally there may be changes in mood, headaches, and a chronic feeling of tiredness. Cushing syndrome is caused by either excessive cortisol-like medication, such as prednisone, or a tumor that either produces or results in the production of excessive cortisol by the adrenal gland. Cases due to a pituitary adenoma are known as Cushing’s disease, which is the second most common cause of Cushing’s syndrome after medication. Several other tumors often referred to as ectopic due to their placement outside the pituitary, may also cause Cushing’s. some of these are associated with inherited disorders such as multiple endocrine neoplasia type 1 and carney complex.

Most cases can be treated and cured. If due to medications, these can often be slowly decreased if still required or slowly stopped. If caused by a tumor, it may be treated by a combination of surgery, chemotherapy, and radiation. If the pituitary gland is affected, other medications may be required to replace its lost function. With treatment, life expectancy is usually normal. Most cases of Cushingoid symptoms are caused by corticosteroid medications, such as those used for asthma, arthritis, eczema, and other inflammatory conditions. Consequently, most patients are effectively treated by carefully tapering off the medication that causes the symptoms.

Global Cushing Syndrome Market – Competitive Landscape

Several pharmaceutical companies are actively engaged in developing and marketing treatments. Companies focus on innovative medications targeting cortisol regulation to address the symptoms of Cushing syndrome. Ongoing research and clinical trials contribute to the evolution of treatment options, fostering competition in this niche therapeutic area. Additionally, collaborations and partnerships within the industry enhance the potential for novel therapies and expand the overall market landscape.

Some of the Key Players in the Global Cushing Syndrome Market Include –

  • Novartis
  • Corcept Therapeutics
  • HRA Pharma
  • Bristol-Myers Squibb
  • Ipsen Biopharmaceuticals
  • Pfizer
  • Roche
  • GlaxoSmithKline Plc
  • Xeris Biopharma
  • Perrigo Co. Plc

Global Cushing Syndrome Market – Growth Drivers

The increasing prevalence of Cushing syndrome also increases the growth of the market. According to the National Center for Biotechnology Information (NCBI), the pooled Cushing syndrome prevalence was 2.2 per 100,000 while the incidence rate was 0.24 per 100,000 persons-years. Growing efforts in educating both healthcare professionals and the general public about Cushing syndrome contribute to early detection and diagnosis, fostering market growth. Ongoing advancements in diagnostic tools, such as imaging techniques and hormonal assays, enhance the accuracy and efficiency of Cushing syndrome diagnosis, driving market expansion. Continuous research and development led to the introduction of novel therapeutic approaches and medications, providing patients with more effective and targeted treatment options and stimulating market growth. The global increase in healthcare spending, especially in developed regions, supports investments in Cushing syndrome research, development, and the adoption of advanced treatment modalities. The trend towards personalized medicine allows for tailored treatment plans based on individual patient characteristics, improving treatment efficacy and driving growth in the Cushing syndrome market. Collaborations between pharmaceutical companies, research institutions, and healthcare organizations facilitate the pooling of resources, expertise, and innovation, accelerating the development of new therapies and expanding market opportunities. Supportive government policies, funding initiatives, and regulatory incentives for rare disease research encourage pharmaceutical companies to invest in Cushing syndrome treatment development, fostering market growth. Increasing healthcare access and improving economic conditions in emerging markets create opportunities for pharmaceutical companies to expand their reach, addressing unmet needs and driving growth in the Cushing syndrome market.

Global Cushing Syndrome Market – Restraints

A significant restraint is the relatively low awareness of Cushing syndrome among the general population and healthcare professionals. This can result in delayed diagnosis and hinder market growth. The complexity of diagnosing Cushing syndrome, often requiring tests, poses a restraint. Diagnostics challenges can lead to underdiagnosis or misdiagnosis, impacting the market’s expansion. Economic constraints in certain regions limit access to advanced diagnostic tools and treatments. According to the National Center for Biotechnology Information (NCBI), the annual cost for treatment of Cushing syndrome is USD 9,353 and other Cushing syndrome-related cost is USD 4,957. Affordability issues may impede the adoption of innovative therapies, particularly in developing countries. Disparities in healthcare infrastructure and resources among different regions create challenges in providing standardized care for Cushing syndrome patients, affecting treatment outcomes. Existing treatments for Cushing syndrome can have side effects, influencing patient adherence and overall market acceptance. The need for safer and more tolerable therapies remains a key restraint. Stringent regulatory requirements for drug approval can pose a challenge for pharmaceutical companies, leading to delays in bringing new Cushing syndrome treatments to the market. Intense competition among pharmaceutical companies in the Cushing syndrome market may result in pricing pressures, impacting profit margins and potentially limiting investment in research and development. Challenges in recruiting a sufficient number of patients for clinical trials can slow down the development of new therapies. This can be attributed to the rarity of the condition and the need for specific patient profiles in trials.

Global Cushing Syndrome Market – Opportunities

Opportunities exist for pharmaceutical companies to collaborate on global awareness campaigns. Increasing awareness about Cushing syndrome can lead to earlier diagnosis and expanded market potential. Untapped markets in developing regions provide opportunities for pharmaceutical companies to expand their footprint. Tailoring treatments based on individual patient profiles presents a significant opportunity. Advancements in personalized medicine may lead to more effective and targeted therapies for Cushing syndrome patients. The integration of technology, such as telemedicine and digital health solutions, offers opportunities to enhance patient care and improve remote monitoring, especially in regions with limited healthcare infrastructure. Opportunities exist for pharmaceutical companies to collaborate with governments and healthcare agencies on initiatives that promote Cushing syndrome awareness, diagnosis, and treatment, potentially unlocking new market segments.

Global Cushing Syndrome Market – Geographical Insight

The market for global Cushing syndrome is segmented into regions such as North America, Latin America, Europe, Asia-Pacific, the Middle East & Africa. North America is the largest market for Cushing syndrome due to advanced healthcare infrastructure and a high level of awareness. Pharmaceutical companies like Novartis and Strong Bridge Biopharma are actively involved in research a development, contributing to a competitive landscape. European countries, with their well-established healthcare systems, witness a competitive Cushing syndrome market. Access to diagnostic tools and a range of treatment options is relatively high. The Asia-Pacific region faces challenges related to awareness and healthcare infrastructure disparities.

Global Cushing Syndrome Market – Key Development

  • On November 29, 2023, Harrow completes the transfer of the TRIESENCE® new drug application.
  • On September 14, 2023, Zomedica announced an expansion market opportunity for the Truforma (R) diagnostic platform with the launch of the first-and-only point-of-care eACTH assay for diagnosis and management of Cushing’s disease in Horse.
  • On December 30, 2021, Xeris Biopharma announced U.S. FDA approval of Recorlev® for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome.
  • On March 9, 2020, Competition aplenty as Novartis isturisa is FDA-approved to treat cushing’s disease.
Complete the form below and we'll get back to you shortly
Table of Content
Complete the form below and we'll get back to you shortly

Research Methodology: Aspects

Market research is a crucial tool for organizations aiming to navigate the dynamic landscape of customer preferences, business trends, and competitive landscapes. At Cognizance Market Research, acknowledging the importance of robust research methodologies is vital to delivering actionable insights to our clientele. The significance of such methodologies lies in their capability to offer clarity in complexity, guiding strategic management with realistic evidence rather than speculation. Our clientele seek insights that excel superficial observations, reaching deep into the details of consumer behaviours, market dynamics, and evolving opportunities. These insights serve as the basis upon which businesses craft tailored approaches, optimize product offerings, and gain a competitive edge in an ever-growing marketplace.

The frequency of information updates is a cornerstone of our commitment to providing timely, relevant, and accurate insights. Cognizance Market Research adheres to a rigorous schedule of data collection, analysis, and distribution to ensure that our reports reflect the most current market realities. This proactive approach enables our clients to stay ahead of the curve, capitalize on emerging trends, and mitigate risks associated with outdated information.

Our research process is characterized by meticulous attention to detail and methodological rigor. It begins with a comprehensive understanding of client objectives, industry dynamics, and research scope. Leveraging a combination of primary and secondary research methodologies, we gather data from diverse sources including surveys, interviews, industry reports, and proprietary databases. Rigorous data analysis techniques are then employed to derive meaningful insights, identify patterns, and uncover actionable recommendations. Throughout the process, we remain vigilant in upholding the highest standards of data integrity, ensuring that our findings are robust, reliable, and actionable.

Key phases involved in in our research process are mentioned below:


Understanding Clients’ Objectives:

Extensive Discussions and Consultations:

  • We initiate in-depth discussions and consultations with our clients to gain a comprehensive understanding of their objectives. This involves actively listening to their needs, concerns, and aspirations regarding the research project.
  • Through these interactions, we aim to uncover the underlying motivations driving their research requirements and the specific outcomes they hope to achieve.

Industry and Market Segment Analysis:

  • We invest time and effort in comprehensively understanding our clients’ industry and market segment. This involves conducting thorough research into market trends, competitive dynamics, regulatory frameworks, and emerging opportunities or threats.
  • By acquiring a deep understanding of the broader industry landscape, we can provide context-rich insights that resonate with our clients’ strategic objectives.

Target Audience Understanding:

  • We analyze our clients’ target audience demographics, behaviors, preferences, and needs to align our research efforts with their consumer-centric objectives. This entails segmenting the audience based on various criteria such as age, gender, income level, geographic location, and psychographic factors.
  • By understanding the nuances of the target audience, we can tailor our research methodologies to gather relevant data that illuminates consumer perceptions, attitudes, and purchase intent.


Identifying Challenges and Opportunities:

  • We proactively identify the challenges and opportunities facing our clients within their respective industries. This involves conducting SWOT (Strengths, Weaknesses, Opportunities, Threats) analyses and competitive benchmarking exercises.
  • By identifying potential obstacles and growth drivers, we can provide strategic recommendations that help our clients navigate complexities and capitalize on emerging opportunities effectively.

Grasping Specific Goals:

  • We delve into the intricacies of our clients’ objectives to gain clarity on the specific goals they aim to accomplish through the research. This entails understanding their desired outcomes, such as market expansion, product development, or competitive analysis.
  • By gaining a nuanced understanding of our clients’ goals, we can tailor our research approach to address their unique challenges and opportunities effectively.

Data Collection:


Primary Research Process:

  • Surveys: We design and administer surveys tailored to capture specific information relevant to our clients’ objectives. This may involve employing various survey methodologies, such as online, telephone, or face-to-face interviews, to reach target audiences effectively.
  • Interviews: We conduct structured or semi-structured interviews with key stakeholders, industry experts, or target consumers to gather in-depth insights and perspectives on relevant topics. These interviews allow us to probe deeper into specific issues and uncover valuable qualitative data.
  • Focus Groups: We organize focus group discussions with carefully selected participants to facilitate interactive discussions and gather collective opinions, attitudes, and preferences. This qualitative research method provides rich contextual insights into consumer behaviors and perceptions.
  • Observations: We conduct observational research by directly observing consumer behaviors, interactions, and experiences in real-world settings. This method enables us to gather objective data on consumer actions and reactions without relying on self-reported information.

Secondary Research Process:

  • Literature Review: We conduct comprehensive literature reviews to identify existing studies, academic articles, and industry reports relevant to the research topic. This helps us gain insights into previous research findings, theoretical frameworks, and best practices.
  • Industry Reports: We analyze industry reports published by reputable trade associations (whitepapers, research studies, etc.), and government agencies (U.S. Census Bureau, Bureau of Labor Statistics, and Securities and Exchange Commission etc.) to obtain macro-level insights into market trends, competitive landscapes, and industry dynamics.
  • Government Publications: We review government publications, such as economic reports, regulatory documents, and statistical databases, to gather relevant data on demographics, market size, consumer spending patterns, and regulatory frameworks.
  • Online Databases: We leverage online databases, such as industry portals, and academic repositories (PubMed Central (PMC), ScienceDirect, SSRN (Social Science Research Network), Directory of Open Access Journals (DOAJ), NCBI, etc.), to access a wide range of secondary data sources, including market statistics, financial data, and industry analyses.



Data Analysis:

The data analysis phase serves as a critical juncture where raw data is transformed into actionable insights that inform strategic decision-making. Through the utilization of analytical methods such as statistical analysis and qualitative techniques like thematic coding, we uncover patterns, correlations, and trends within the data. By ensuring the integrity and validity of our findings, we strive to provide clients with accurate and reliable insights that accurately reflect the realities of the market landscape.


Transformation of Raw Data:

  • Upon collecting the necessary data, we transition into the data analysis phase, where raw data is processed and transformed into actionable insights. This involves organizing, cleaning, and structuring the data to prepare it for analysis.

Utilization of Analytical Methods:

  • Depending on the research objectives, we employ a diverse range of analytical methods to extract meaningful insights from the data. These methods include statistical analysis, trend analysis, regression analysis, and qualitative coding.

Statistical Analysis:

  • Statistical tools are instrumental in uncovering patterns, correlations, and trends within the data. By applying statistical techniques such as descriptive statistics, hypothesis testing, and multivariate analysis, we can discern relationships and derive valuable insights.

Qualitative Analysis Techniques:

  • In addition to quantitative analysis, we leverage qualitative analysis techniques to gain deeper insights from qualitative data sources such as interviews or open-ended survey responses. One such technique is thematic coding, which involves systematically categorizing and interpreting themes or patterns within qualitative data.

Integrity and Validity Maintenance:

  • Throughout the analysis process, we maintain a steadfast commitment to upholding the integrity and validity of our findings. This entails rigorous adherence to established methodologies, transparency in data handling, and thorough validation of analytical outcomes.

Data Validation:

The final phase of our research methodology is data validation, which is essential for ensuring the reliability and credibility of our findings. Validation involves scrutinizing the collected data to identify any inconsistencies, errors, or biases that may have crept in during the research process. We employ various validation techniques, including cross-referencing data from multiple sources, conducting validity checks on survey instruments, and seeking feedback from independent experts or peer reviewers. Additionally, we leverage internal quality assurance protocols to verify the accuracy and integrity of our analysis. By subjecting our findings to rigorous validation procedures, we instill confidence in our clients that the insights they receive are robust, reliable, and trustworthy.


Importance of Data Validation:

  • Data validation is the final phase of the research methodology, crucial for ensuring the reliability and credibility of the findings. It involves a systematic process of reviewing and verifying the collected data to detect any inconsistencies, errors, or biases.

Scrutiny of Collected Data:

  • The validation process begins with a thorough scrutiny of the collected data to identify any discrepancies or anomalies. This entails comparing data points, checking for outliers, and verifying the accuracy of data entries against the original sources.

Validation Techniques:

  • Various validation techniques are employed to ensure the accuracy and integrity of the data. These include cross-referencing data from multiple sources to corroborate findings, conducting validity checks on survey instruments to assess the reliability of responses, and seeking feedback from independent experts or peer reviewers to validate the interpretation of results.

Internal Quality Assurance Protocols:

  • In addition to external validation measures, internal quality assurance protocols are implemented to further validate the accuracy of the analysis. This may involve conducting internal audits, peer reviews, or data validation checks to ensure that the research process adheres to established standards and guidelines.
- Get Started -

Get insights that lead to new growth opportunities

Need a Custom Report?

We can customize every report – free of charge – including purchasing stand-alone sections or country-level reports

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Business Development

small c popup.png
Buy Now
small c popup.png
Complete the form below and we'll get back to you shortly
small c popup.png
Complete the form below and we'll get back to you shortly
small c popup.png
Complete the form below and we'll get back to you shortly
Ask an Expert